Complement in Experimental Autoimmune Encephalomyelitis Revisited: C3 is Required for Development of Maximal Disease

類似資料

• p150/95 (CD11c/CD18) Expression Is Required for the Development of Experimental Autoimmune Encephalomyelitis
  著者:: Bullard, Daniel C., 等
  出版事項: (2007)
• Differential ICAM-1 Isoform Expression Regulates the Development and Progression of Experimental Autoimmune Encephalomyelitis
  著者:: Hu, Xianzhen, 等
  出版事項: (2010)
• γδ T cells in Experimental Autoimmune Encephalomyelitis: Early Trafficking Events and Cytokine Requirements
  著者:: Wohler, Jillian E., 等
  出版事項: (2009)
• Deletion of both ICAM-1 and C3 Enhances Severity of Experimental Autoimmune Encephalomyelitis Compared to C3-Deficient Mice
  著者:: Smith, Sherry S., 等
  出版事項: (2008)
• The Complement Anaphylatoxin Receptors Are Not Required for the Development of Experimental Autoimmune Uveitis
  著者:: Read, Russell W., 等
  出版事項: (2013)